Viewing Study NCT05523895

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:37 PM
Ignite Modification Date: 2026-01-27 @ 10:26 AM
Study NCT ID: NCT05523895
Status: COMPLETED
Last Update Posted: 2025-08-24
First Post: 2022-08-29
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Pimavanserin for the Treatment of Irritability Associated With Autism Spectrum Disorder
Sponsor: ACADIA Pharmaceuticals Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Irritability Associated With Autism Spectrum Disorder View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Randomized View
None Placebo-controlled View